More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in large quantities to treat diseases like Ebola or cancer. Companies, like Eli Lilly and Co and Regeneron Pharmaceuticals in the United States, are trying to use this approach to develop their treatments.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XKxYxx
via IFTTT
0 comments:
Post a Comment